Document Detail

Complement inhibition to treat myocardial infarction?
MedLine Citation:
PMID:  22696664     Owner:  NLM     Status:  MEDLINE    
The authors describe the case of a middle-aged women who presented with an acute myocardial infarction due to thrombotic occlusion of angiographically normal coronary arteries. Coronary thrombosis was caused by a hypercoagulable state related to a haemolytic crisis of paroxysmal nocturnal haemoglobinuria and the patient was treated conservatively with antithrombotic agents. The clinical course was complicated by both severe bleeding and thrombotic complications and the patient eventually died of a massive intracerebral haemorrhage. The rapid occurrence of complications inhibited a timely administration of a specific treatment for complement-mediated haemolysis (eculizumab).
Bernhard Gerber; Tatiana Kyburz; Walter H Reinhart; Piero O Bonetti; Georg Stussi
Related Documents :
22308274 - Comparison of exercise treadmill testing with cardiac computed tomography angiography a...
22119914 - The influence of obesity on progression of coronary arteriosclerosis and clinical cours...
22572634 - Clinical and angiographic characteristics of patients with coronary artery ectasia.
11563684 - Beta-blockers and heart failure: meta-analysis of mortality trials.
20305934 - An intraoperative transesophageal echocardiography-guided maneuver to assist the remova...
11723364 - Hypertension images: electrocardiographic left ventricular hypertrophy.
Publication Detail:
Type:  Case Reports; Journal Article     Date:  2011-04-26
Journal Detail:
Title:  BMJ case reports     Volume:  2011     ISSN:  1757-790X     ISO Abbreviation:  BMJ Case Rep     Publication Date:  2011  
Date Detail:
Created Date:  2012-06-14     Completed Date:  2013-09-06     Revised Date:  2013-12-05    
Medline Journal Info:
Nlm Unique ID:  101526291     Medline TA:  BMJ Case Rep     Country:  England    
Other Details:
Languages:  eng     Pagination:  -     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antibodies, Monoclonal, Humanized / therapeutic use
Complement Inactivating Agents / therapeutic use
Coronary Angiography
Fatal Outcome
Hemoglobinuria, Paroxysmal / complications*,  drug therapy
Myocardial Infarction / diagnosis*,  etiology
Reg. No./Substance:
0/Antibodies, Monoclonal, Humanized; 0/Complement Inactivating Agents; A3ULP0F556/eculizumab

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Live-attenuated lentivirus immunization modulates innate immunity and inflammation while protecting ...
Next Document:  Non-Hodgkin lymphoma presenting with numb chin syndrome.